Highlights for me are:
* the targeted reduction in debt from $5m to $2.8m this financial year (via rights issue and internally generated reduction)
* sales of ironman hybrid in two states and good customer feedback
* strong margins - the company is not only innovative, but seems to be earning very good margins on its innovations
* it's taking its innovations into overseas markets - distribution deal in Canadian market, Malaysia could be next
* pipeline of innovations - despite very small R&D spend in recent years
Maybe I'm missing something but this company seems to have turned itself around quite remarkably - and now has multiple avenues for growth. Credit to the management team (seems to me to have a very good blend of skills and experience). Let's hope this team stays together for many more years. I'm very happy to support the rights issue.
SRH Price at posting:
11.5¢ Sentiment: Buy Disclosure: Held